ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.00%
S&P ASX All Technology
3,075.00
0.00%
Brent Oil
81.125
-0.21%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
67,835.19
0.16%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Pro-Pharmaceuticals, (PRW)

  7. Pro-Pharmaceuticals, (PRW) News

PRW

Pro (PRW)

Pro-Pharmaceuticals,
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PRW
DateTimeSourceHeadlineSymbolCompany
06/01/200909:00Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
31/12/200823:00Business WirePro-Pharmaceuticals Provides Year-End UpdateAMEX:PRWPro-Pharmaceuticals,
20/11/200823:00Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
20/11/200823:00Business WirePro-Pharmaceuticals Files Registration Statement for Rights Offering to Its ShareholdersAMEX:PRWPro-Pharmaceuticals,
20/11/200809:23Edgar (US Regulatory)Securities Registration Statement (S-1)AMEX:PRWPro-Pharmaceuticals,
14/11/200823:00Business WirePro-Pharmaceuticals to Commence Rights Offering to ShareholdersAMEX:PRWPro-Pharmaceuticals,
14/11/200808:17Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
14/11/200808:15Business WirePro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext USAMEX:PRWPro-Pharmaceuticals,
07/11/200823:31Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
07/11/200823:30Business WirePro-Pharmaceuticals Reports Third Quarter ResultsAMEX:PRWPro-Pharmaceuticals,
07/11/200823:17Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:PRWPro-Pharmaceuticals,
06/11/200823:00Business WirePro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment ConferenceAMEX:PRWPro-Pharmaceuticals,
06/10/200822:00Business WirePro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDAAMEX:PRWPro-Pharmaceuticals,
24/09/200801:27Edgar (US Regulatory)Pro Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)AMEX:PRWPro-Pharmaceuticals,
18/09/200821:00Business WirePro-Pharmaceuticals' Management Outlines Strategic InitiativesAMEX:PRWPro-Pharmaceuticals,
28/08/200821:00Business WireFDA Grants IND for Pro-Pharmaceuticals' DAVANAT(R) to Treat Breast Cancer PatientAMEX:PRWPro-Pharmaceuticals,
08/08/200821:10Edgar (US Regulatory)Pro Pharmaceuticals Inc - Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
08/08/200821:05Business WirePro-Pharmaceuticals Reports Second Quarter ResultsAMEX:PRWPro-Pharmaceuticals,
08/08/200820:55Edgar (US Regulatory)Pro Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:PRWPro-Pharmaceuticals,
06/08/200821:00Business WirePro-Pharmaceuticals Granted Pre-IND Meeting for Anti-Hypoxia DrugAMEX:PRWPro-Pharmaceuticals,
04/08/200821:00Business WireAmex Accepts Pro-Pharmaceuticals Compliance PlanAMEX:PRWPro-Pharmaceuticals,
15/07/200821:00Business WirePro-Pharmaceuticals Has Requested a Pre-IND Meeting with the U.S. Food and Drug AdministrationAMEX:PRWPro-Pharmaceuticals,
11/07/200821:00Business WirePro-Pharmaceuticals' Senior Executives to Be Featured on PBS' "Wealth & Wisdom"AMEX:PRWPro-Pharmaceuticals,
10/07/200821:00Business WirePro-Pharmaceuticals Appoints Noted Pioneer in Liver Diseases, Scott L. Friedman, M.D., to Scientific Advisory BoardAMEX:PRWPro-Pharmaceuticals,
09/07/200821:00Business WirePro-Pharmaceuticals and Sanghyon Chemical Ink Historic Agency AgreementAMEX:PRWPro-Pharmaceuticals,
25/06/200821:00Business WirePro-Pharmaceuticals' Executives Contribute to Definitive Book on GalectinsAMEX:PRWPro-Pharmaceuticals,
20/06/200823:20Edgar (US Regulatory)Pro Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:PRWPro-Pharmaceuticals,
20/06/200820:00Edgar (US Regulatory)Pro Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)AMEX:PRWPro-Pharmaceuticals,
10/06/200821:02Edgar (US Regulatory)Pro Pharmaceuticals Inc - Withdrawal of Registration Statement (RW)AMEX:PRWPro-Pharmaceuticals,
03/06/200806:32Edgar (US Regulatory)Pro Pharmaceuticals Inc - Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
 Showing the most relevant articles for your search:AMEX:PRW

Your Recent History

ASX
FMG
Fortescue
NYSE
KO
Coca Cola
ASX
NCM
Newcrest Mining
CCOM
SILVER
SILVER
ASX
XMM
S&P ASX 300 Metals and M...
ASX
ANZ
Australia And New Zealan...
ASX
XAO
Australian SE All Ordina...
ASX
MQG
Macquarie
ASX
NAB
National Australia Bank
NASDAQ
AAPL
Apple
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
NYSE
NKE
Nike
ASX
CBA
Commonwealth Bank Of Aus...
NYSE
MCD
McDonalds
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved